Inversion of stereospecificity of vanillyl-alcohol oxidase by Heuvel, Robert H.H. van den et al.
  
 University of Groningen
Inversion of stereospecificity of vanillyl-alcohol oxidase
Heuvel, Robert H.H. van den; Fraaije, Marco W.; Ferrer, Miriam; Mattevi, Andrea; Berkel,
Willem J.H. van
Published in:
Proceedings of the National Academy of Sciences
DOI:
10.1073/pnas.160175897
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2000
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Heuvel, R. H. H. V. D., Fraaije, M. W., Ferrer, M., Mattevi, A., & Berkel, W. J. H. V. (2000). Inversion of
stereospecificity of vanillyl-alcohol oxidase. Proceedings of the National Academy of Sciences, 97(17).
https://doi.org/10.1073/pnas.160175897
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Inversion of stereospecificity of
vanillyl-alcohol oxidase
Robert H. H. van den Heuvel*, Marco W. Fraaije†‡, Miriam Ferrer*, Andrea Mattevi†,
and Willem J. H. van Berkel*§
*Department of Biomolecular Sciences, Laboratory of Biochemistry, Wageningen University, Dreijenlaan 3, 6703 HA Wageningen, The Netherlands; and
†Department of Genetics and Microbiology, University of Pavia, Via Abbiategrasso 207, 27100 Pavia, Italy
Edited by Vincent Massey, University of Michigan Medical School, Ann Arbor, MI, and approved June 15, 2000 (received for review April 18, 2000)
Vanillyl-alcohol oxidase (VAO) is the prototype of a newly recognized
family of structurally related oxidoreductases sharing a conserved
FAD-binding domain. The active site of VAO is formed by a cavity
where the enzyme is able to catalyze many reactions with phenolic
substrates. Among these reactions is the stereospecific hydroxylation
of 4-ethylphenol-forming (R)-1-(4*-hydroxyphenyl)ethanol. During
this conversion, Asp-170 is probably critical for the hydration of the
initially formed p-quinone methide intermediate. By site-directed
mutagenesis, the putative active site base has been relocated to the
opposite face of the active site cavity. In this way, a change
in stereospecificity has been achieved. Like native VAO, the single
mutants T457E, D170A, and D170S preferentially converted 4-ethyl-
phenol to the (R)-enantiomer of 1-(4*-hydroxyphenyl)ethanol. The
double mutants D170AyT457E and D170SyT457E exhibited an in-
verted stereospecificity with 4-ethylphenol. Particularly, D170Sy
T457E was strongly (S)-selective, with an enantiomeric excess of 80%.
The crystal structure of D170SyT457E, in complex with trifluorometh-
ylphenol, showed a highly conserved mode of ligand binding and
revealed that the distinctive catalytic properties of this mutant are not
caused by major structural changes.
Vanillyl-alcohol oxidase (VAO; EC 1.1.3.38) is a flavoenzymefrom Penicillium simplicissimum containing a covalently
bound FAD. The enzyme is the prototype of a newly recognized
family of structurally related oxidoreductases sharing a con-
served FAD-binding domain (1). Prominent members of this
family include MurB (UDP-N-acetylenolpyruvylglucosamine re-
ductase) (2), the molybdenum enzyme carbon monoxide dehy-
drogenase (3), and the flavocytochrome p-cresol methylhydroxy-
lase (PCMH) (4). VAO is active with a wide range of phenolic
compounds (5, 6). Conversion of the physiological substrate
4-(methoxymethyl)phenol by VAO involves the initial transfer of
a hydride from the substrate to the flavin, resulting in the
formation of a complex between the two-electron reduced
enzyme and the p-quinone methide product intermediate. Next,
the reduced flavin is reoxidized by molecular oxygen with the
concomitant hydration of the p-quinone methide (7), as shown
in Scheme 1:
The crystal structure of VAO represents the first crystal struc-
ture of a flavoenzyme with a histidyl-bound flavin (8). Each
VAO monomer comprises two domains, with the cap domain
covering the active site cavity and the larger domain forming the
binding site of the FAD prosthetic group. All present evidence
suggests that the covalent anchoring of the flavin is a self-
catalytic process (9). From the properties of His-422 variants, it
was established that the covalent interdomain interaction with
His-422 serves to increase the flavin redox potential, an essential
feature for efficient redox catalysis (10). Another important
residue in the enzyme active site is Asp-170. The side chain of
this acidic residue is only 3.6 Å from flavin N5 and the reactive
methylene group of the phenolic substrate (8). From studies on
Asp-170 variants, we recently showed that Asp-170 is important
for maintaining the high redox potential of the enzyme and thus
its reactivity (11). Furthermore, these studies revealed that
Asp-170 assists in covalent flavinylation, possibly by donating a
proton to flavin N5 (11). It has been suggested that, in the related
flavocytochrome PCMH, Glu-380 fulfills a similar role during
the flavinylation process (4, 11, 12).
VAO and PCMH have a similar substrate specificity (6, 13,
14), and the active site architecture of both enzymes is highly
conserved (4, 8). However, VAO preferentially converts 4-eth-
ylphenol and 4-propylphenol to the corresponding (R)-1-(49-
hydroxyphenyl)alcohols (14), whereas PCMH favors the
production of the (S)-enantiomers (15, 16). The structural
determinants involved in the stereochemistry of VAO and
PCMH are unknown. It has been proposed that Asp-170 in VAO
(8, 11) and the equivalent Glu-380 in PCMH (4) might activate
the water involved in substrate conversion. However, in PCMH
another acidic residue (Glu-427) is situated near the reactive
carbon of bound p-cresol at the opposite face of the substrate (4).
In VAO, this position is occupied by Thr-457 (Fig. 1), raising the
possibility that this structural variation plays a role in the
opposite stereospecificity of water attack.
To investigate this hypothesis and the function of Asp-170 in
the active site of VAO in further detail, we have generated the
single mutant T457E and the double mutants D170AyT457E and
D70SyT457E. Here, we present the biochemical and structural
characterization of the first VAO variant with an inverted
stereospecificity. Furthermore, evidence is provided that Glu-
457 may substitute for Asp-170 in promoting the covalent
tethering of the flavin ring.
This paper was submitted directly (Track II) to the PNAS office.
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Materials. Escherichia coli strain DH5aF9 (18) and the plasmid
pUCBM20 (Boehringer Mannheim) were used for cloning
throughout, whereas E. coli strain TG2 (19) and the plasmid
pEMBL19(2) (Boehringer Mannheim) were used for expres-
sion of the vaoA gene. Yeast extract and tryptone peptone
extract were from Difco. Racemic 1-(49-hydroxyphenyl)ethanol
was synthesized as described (14), and (R)-1-(49-hydroxyphe-
nyl)ethanol was obtained from the enzymatic conversion of
4-ethylphenol. All other chemicals were purchased as reported
earlier (6, 11).
Site-Directed Mutagenesis and Enzyme Purification. pBC11 (wild-
type), pBC15 (D170S), and pBC16 (D170A) were constructed as
described before (11). The SalI-KpnI fragment of pBC11 was
ligated in pUCBM20 and used for PCR-based mutagenesis with
the oligonucleotide 59-GATTTTATCGGCGAGTTCA-
CAGTCGGTATG-39 (where GAG denotes the replacement of
Thr by Glu). The mutated SalI–KpnI fragment was ligated into
pBC11, pBC15, and pBC16, yielding pBC22 (T457E), pBC24
(D170SyT457E), and pBC23 (D170AyT457E), respectively. Suc-
cessful mutagenesis was confirmed by plasmid sequencing.
Transformed E. coli cells were grown in Luria-Bertani medium
supplemented with 75 mgyml ampicillin and 0.25 mM isopropyl
b-D-thiogalactopyranoside (20). The VAO mutant proteins were
purified according to a previously established procedure (11).
Enzyme purity was checked by SDSyPAGE and by analytical gel
filtration using a Superdex (Amersham Pharmacia) 200 HR
10y30 column.
Analytical Methods. All experiments were performed in air-
saturated 50 mM potassium phosphate buffer (pH 7.5) at 25°C,
unless stated otherwise. Molar absorption coefficients for pro-
tein-bound flavin and the fraction of covalently bound flavin
were determined as described previously (11). SDSyPAGE was
carried out in 12.5% slab gels essentially as reported earlier (21,
22). The redox potentials of the VAO mutants were determined
by the xanthineyxanthine oxidase method (23), essentially as
described before (10, 11).
HPLC experiments were performed with an Applied Biosys-
tems pump equipped with a Waters 996 photodiode array
detector and a 3.9 3 150-mm Waters Novapak C18 column,
essentially as described earlier (6). GC analysis was performed
on a Varian Star 3400 CX gas chromatograph with a 50-m
capillary Chrompack CP-cyclodextrin column (0.25-mm internal
diameter and 0.25-mM film thickness) having CP-cyclodextrin-
B-2,3,6-M-19 as the chiral stationary phase. The temperature
program started at 80°C, followed by an increase with 7°C min21
to 160°C, which was held for 30 min (14).
VAO activity was determined by following absorption spectral
changes of aromatic substrates or by measuring the rate of
product formation by HPLC (6, 11). Rapid reaction stopped-
flow kinetics were conducted with a Hi-Tech SF-51 apparatus
equipped with a Hi-Tech M300 monochromator diode-array
detector (Salisbury, U.K.), essentially as described (7). Decon-
volution of spectral data were performed by using the SPECFIT
GLOBAL ANALYSIS program version 2.10 (Spectrum Software
Associates, Chapel Hill, NC).
Crystallographic Analysis of Mutant D170SyT457E. Crystals of the
double mutant D170SyT457E were grown by using the hang-
ing-drop vapor diffusion method, in conditions similar to those
for wild-type VAO (8). Brief ly, protein solutions containing 10
mg protein per ml in 50 mM potassium phosphate buffer (pH
7.5) were equilibrated against a reservoir solution containing
100 mM sodium acetateyhydrochloride (pH 4.6) and 3%
(wtyvol) PEG 4000. Binding of the inhibitor trif luoromethyl-
phenol was achieved by soaking the crystals for 5 h in a solution
containing 10 mM of the substrate analog. Diffraction
data were measured from a single crystal at the X11 beam line
of the European Molecular Biology LaboratoryyDeutsches
Elektronen Synchrotron (Hamburg, Germany) by using a
MarCCD detector at 100 K. Before data collection, the crystal
was exposed for a few seconds to a cryoprotecting solution
containing 20% (vol/vol) PEG 400y10% (wt/vol) PEG 4000y50
mM sodium acetate/hydrochloride (pH 4.6). The data were
processed by using MOSF LM (24) and programs of the CCP4
package (25). The double mutant crystals are isomorphous to
those of wild-type enzyme and belong to space group I4 with
unit cell parameters a 5 b 5 131.28, c 5 134.36 Å. Crystal-
lographic refinement was performed with the REFMAC pro-
gram (26). A bulk solvent correction was applied by using the
programs of the CCP4 package whereas the positions of ordered
solvent molecules were located by using ARP (27). The free
R-factor was used to monitor the progress of the refinement.
Electron density maps were visually inspected by using the
program O (28). See Table 2 for a summary of the final
refinement statistics.
Results
Enzyme Characterization. The purified VAO mutants T457E,
D170AyT457E, and D170SyT457E were bright yellow, and their
near UV absorption properties were virtually identical to wild-
type enzyme (29). Fluorescence analysis of unstained SDS gels
showed that the mutant enzymes were as fluorescent as wild-
type VAO. This fluorescence behavior, and the fact that the
mutants did not release any flavin upon trichloroacetic acid
treatment (29), indicated that all f lavin was covalently bound.
Moreover, analytical gel filtration revealed that the mutants
were mainly octameric, with only a small fraction in the dimeric
Fig. 1. Drawing of the active site cavity of isoeugenol-complexed VAO. The
side chains of Asp-170 and Thr-457 in VAO align with Glu-380 and Glu-427 in
PCMH, respectively. This figure was prepared with MOLSCRIPT (17).
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form. This oligomerization behavior is similar to wild-type VAO
(30, 31).
The redox potentials of the VAO mutants were measured by
the xanthineyxanthine oxidase system (23) by using the reference
dyes thionin (Em 5 160 mV) and methylene blue (Em 5 111
mV). As found for wild-type enzyme (10), all three mutants were
reduced in a single two-electron step, with no formation of any
semiquinone (Fig. 2). On plotting log (EoxyEred) vs. log (dyeoxy
dyered) (32, 33), midpoint redox potentials of 120 6 1 mV,
122 6 2 mV, and 131 6 2 mV were estimated for T457E,
D170AyT457E, and D170SyT457E, respectively. These values
are lower than for wild-type VAO (Em 5 155 mV) (10), but
considerably higher than the value reported for D170S (Em 5
291 mV) (11).
Catalytic Properties. VAO converts 4-(methoxymethyl)phenol
with a maximum turnover rate of 3.1 s21 and a Km value of 55
mM (7). Replacement of Thr-457 by Glu decreased the catalytic
efficiency (kcatyKm) with this substrate by about a factor of 7
(Table 1). The double mutants D170AyT457E and D170Sy
T457E were rather poor catalysts (Table 1). Nevertheless, these
mutants were considerably more active with 4-(methoxymeth-
yl)phenol than D170A and D170S (11).
Previous studies have shown that the turnover rate of VAO
with 4-(methoxymethyl)phenol is mainly determined by the rate
of flavin reduction. Moreover, rapid kinetics have established
that, in the absence of oxygen, the reduced enzyme forms a
rather stable complex with the p-quinone methide intermediate
of the substrate (7), shown in Scheme 2:








In analogy to wild-type enzyme, anaerobic reduction of T457E
by 4-(methoxymethyl)phenol followed monoexponential kinet-
ics, resulting in fully reduced enzyme when monitored at 440 nm.
The maximum reduction rate of 1.2 s21 approached the maxi-
mum turnover rate (Table 1), indicating that flavin reduction
mainly determines the rate of overall catalysis. Diode-array
spectral analysis of the anaerobic reduction of T457E with
4-(methoxymethyl)phenol revealed the formation of a strong
absorption band with a maximum at 364 nm, representing the
binary complex between the reduced enzyme and the p-quinone
methide product intermediate. As in wild-type VAO (11), the
decomposition of this complex, forming 4-hydroxybenzaldehyde,
was very slow (kobs 5 0.01 s21).
The rate of anaerobic reduction of D170AyT457E and
D170SyT457E by 4-(methoxymethyl)phenol was 0.02 s21 and
0.03 s21, respectively. Again, these values are in the same range
as the corresponding turnover rates (Table 1). With both double
mutants, the flavin became fully reduced in a monophasic
process with the concomitant formation of 4-hydroxybenzalde-
hyde. In contrast to T457E and wild-type VAO, no stabilization
of the p-quinone methide-reduced enzyme complex was ob-
served. A similar behavior was recently observed for D170A and
D170S (11).
Stereochemistry of the Mutant Enzymes. Wild-type VAO hydroxy-
lates 4-ethylphenol stereospecifically to (R)-1-(49-hydroxyphe-
nyl)ethanol, with an enantiomeric excess of 94% (14). To probe
the role of Asp-170 and Thr-457 in this reaction, we studied the
conversion of 4-ethylphenol by the single mutants T457E,
D170A, and D170S and by the double mutants D170AyT457E
and D170SyT457E. The turnover rates of the mutant enzymes
with 4-ethylphenol were about two orders of magnitude lower
than with wild-type VAO (not shown). Nevertheless, all mutants
catalyzed the formation of 1-(49-hydroxyphenyl)ethanol in high
yield. As found for native VAO (14), only minor amounts of the
side product 1-(49-hydroxyphenyl)ethene were formed. T457E
showed a high preference for the formation of the (R)-
enantiomer of 1-(49-hydroxyphenyl)ethanol (Fig. 3A). D170A
and D170S were less (R)-selective, with enantiomeric excess
Fig. 2. Anaerobic reduction of 8 mM D170SyT457E by the xanthineyxanthine
oxidase system (23) in the presence of 8 mM thionin in 50 mM potassium
phosphate buffer (pH 7.5) at 25°C. Spectra were taken at regular time intervals
(10 min), and full reduction was achieved after 95 min. The Inset shows the log
(EoxyEred) (measured at 440 nm after correction for thionin) vs. log (dyeoxy
dyered) (measured at 600 nm) plot.
Table 1. Kinetic parameters of wild type VAO and Asp-170yThr-457 mutants with
4-(methoxymethyl)phenol in air-saturated 50 mM potassium phosphate buffer (pH 7.5)
at 25°C
Parameter Wild-type* D170S† D170A† T457E D170SyT457E D170AyT457E
kcat (s21) 3.1 0.004 0.001 1.3 0.05 0.02
Km (mM) 55 ND ND 168 238 65
kred (s21)‡ 3.3 0.005 0.002 1.2 0.03 0.02
ND, not determined.
*Data from ref. 7.
†Data from ref. 11.
‡kred was measured at a substrate concentration of 500 mM.








values of 26% and 50%, respectively. The double mutants
exhibited an opposite stereospecificity with 4-ethylphenol. Es-
pecially, D170SyT457E showed a strong preference for the
(S)-enantiomer, with an enantiomeric excess of 80% (Fig. 3B).
Structure of D170SyT457E. The crystal structure of D170SyT457E
in complex with the substrate analog trif luoromethylphenol was
determined at 2.75 Å resolution (Table 2). The inhibitor was
clearly visible in the electron density map of one of the two
crystallographically independent subunits (subunit B). Its ori-
entation in the proximity of the flavin ring was nearly identical
to the orientation in several previously determined enzyme–
inhibitor complex structures (8, 10, 11). Superposition of the
structures of trif luoromethylphenol-complexed D170SyT457E
and isoeugenol-complexed wild-type VAO (8) showed that the
two amino acid replacements did not cause any significant
conformational change, which is reflected in a rms deviation for
all Ca-atoms of only 0.23 Å. The active site cavity of D170Sy
T457E was highly similar to that of wild-type enzyme (8) (Fig.
4) and D170S (11). The Og-atom of Ser-170 in D170SyT457E
points toward flavin N5 at a distance of 3.7 Å from the
isoalloxazine ring. Compared with Ser-170, the newly introduced
Glu-457 is positioned at the opposite side of the substrate-
binding cavity. Its side chain points toward the Ca-atom of
bound trif luoromethylphenol, resulting in a distance between
the carboxylic moiety of Glu-457 and the Ca-atom of the
inhibitor of 3.5 Å. In wild-type VAO, Thr-457 points also toward
this Ca-atom; however, the distance between the inhibitor Ca
and Og of Thr-457 is 6.2 Å (8).
Discussion
The active site topology of VAO is highly similar to that of the
flavocytochrome PCMH(4, 8). Nevertheless, subtle structural
differences between both flavoenzymes exist that are likely of
relevance with respect to the mechanism and specificity of
catalysis. One striking difference is the arrangement of acidic
residues (Fig. 1). The active site of VAO contains a single
aspartate (Asp-170) whose side chain is close to flavin N5 and
the reactive Ca-atom of the substrate (8). In contrast, PCMH
harbors two glutamates at opposite faces of the substrate (4).
From this location, we rationalized that the different arrange-
ment of acidic residues might explain the opposite stereochem-
istry in the reaction with 4-alkylphenols (14, 15, 16).
The spectral and hydrodynamic properties of T457E, D170Ay
T457E, and D170SyT457E were similar to wild-type VAO.
Moreover, the crystal structure of D170SyT457E established
that the introduction of an acidic side chain at position 457 does
not result in any significant structural perturbation. In all three
mutants, and different from D170A and D170S (11), the flavin
prosthetic group was fully covalently bound.
Previous studies have indicated that the covalent interaction
between His-422 and the isoalloxazine ring markedly increases
the redox potential of the flavin cofactor (10). The redox
potentials of D170AyT457E and D170SyT457E were only
slightly lower than that of wild-type VAO, supporting the
proposal that an acidic residue in the active site cavity is required
for maintaining the high redox potential (11). Self-catalytic
covalent flavinylation is thought to occur via initial f lavin
tautomerization (34, 35), followed by donation of a proton to the
iminoquinone methide form of the flavin (12). In VAO, Asp-170
is envisaged to act as the proton donor in this process (11).
Because D170AyT457E and D170SyT457E contained fully co-
valently bound flavin, this indicates that Glu-457 can replace
Asp-170 in the process of covalent flavinylation. The structure
of D170SyT457E showed that the carboxylic moiety of Glu-457
is about 7.0 Å from flavin N5. This distance suggests that
Glu-457 cannot donate a proton directly to the flavin and that
Fig. 3. (A) Stereospecificity of hydroxylation of 4-ethylphenol by wild-type
VAO and Asp-170yThr-457 mutants in 50 mM potassium phosphate buffer (pH
7.5) at 25°C. (R)-1-(49-hydroxyphenyl)ethanol (black) and (S)-1-(49-hydroxy-
phenyl)ethanol (white). (B) Expanded chiral GC separation pattern of the
hydroxylation of 4-ethylphenol by (I) wild-type VAO and (II) D170SyT457E.
Table 2. Data collection and refinement statistics for





Completeness of data, %* 97.3 (95.0)
Multiplicity* 2.4 (2.2)
Intensities Iys* 7.4 (2.1)
Rsym, %*† 11.0 (37.1)
Cell dimensions, Å a 5 b 5 131.28, c 5 134.36
Rfactor, % 22.5
Rfree, % 28.7
No. of ligand atoms 11 (trifluoromethylphenol)
rmsd for ideal value‡
Bond lengths, Å 0.009
Bond angles, ° 2.5
Trigonal atoms, Å 0.019
Planar groups, Å 0.001
*The values relating to the highest resolution shell (2.90–2.75 Å) are given in
brackets.
†Rsym 5 (ï Ij 2 ^Ij&ï y(^Ij&, where Ij is the intensity of an observation of reflection
j and ^Ij& is the average intensity for reflection j.
‡The rms deviations (rmsd) were calculated using the program REFMAC (26).
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the proton might be transferred via a water molecule, as
observed in sarcosine oxidase (12), rather than by direct dona-
tion from Glu-457.
The single mutant T457E was rather active with 4-(methoxym-
ethylphenol) and fully capable of stabilizing the complex be-
tween the reduced enzyme and the p-quinone methide interme-
diate. From this catalytic performance and the relatively high
redox potential of T457E, we conclude that the Thr-457-Glu
replacement has no profound effects on the electrostatic inter-
actions in the enzyme active site. The double mutants reacted
more slowly with 4-(methoxymethylphenol) and did not stabilize
the quinone methide. This behavior strongly supports our earlier
proposal that Asp-170 is essential for efficient redox catalysis by
forming a hydrogen bond with the protonated N5-atom of the
reduced flavin (11).
Wild-type VAO preferentially converts 4-ethylphenol to the
(R)-enantiomer of 1-(49-hydroxyphenyl)ethanol (14). The high
yield of this asymmetric compound results from the stereospecific
attack of a water molecule to the p-quinone methide intermediate
in the active site. The D170AyT457E and D170SyT457E double
mutants exhibit an inverted stereospecificity with 4-ethylphenol.
This (S)-selectivity is likely caused by the attack of a water molecule
from the other side of the substrate. Another possibility for the
inverted stereospecificity is that the substrate is bound in a different
orientation. The crystal structure of D170SyT457E in complex with
trifluoromethylphenol reveals that this possibility is rather unlikely.
In the double mutant, the carboxylic moiety of Glu-457 is posi-
tioned at the opposite face of the substrate analog and only 3.5 Å
from the Ca-atom. This indicates that, in the double mutants,
Glu-457 directs the stereospecific water attack to the planar qui-
none methide intermediate, presumably by acting as an active site
base (Fig. 5). In this respect, it is important to note that the single
mutant T457E exhibits a strong preference for the formation of the
(R)-enantiomer of 1-(49-hydroxyphenyl)ethanol. This preference
suggests that, in this particular mutant, Asp-170 favorably competes
with Glu-457 for the site of water attack. The (R)-selectivity of
T457E is in marked contrast with the stereochemical properties of
PCMH. Like T457E, PCMH contains two acidic residues at oppo-
site faces of the substrate binding site (4) but hydroxylates 4-eth-
ylphenol preferably to (S)-1-(49-hydroxyphenyl)ethanol (15, 16).
Further mutagenesis studies are needed to establish whether the
opposite stereospecificity of PCMH and T457E is related to the
different type of acidic side chains (i.e., Glu-380 and Asp-170,
respectively). Nevertheless, the above data show that subtle varia-
tions in active site topology determine the outcome of the enzyme
stereospecificity and reinforce the idea that inversion of enantio-
selectivity can be generally carried out without major structural
reconstruction (36). Our results are also in line with studies from
medium-chain acyl-CoA dehydrogenase, where it was demon-
strated that a functional glutamate involved in substrate dehydro-
genation can be relocated in the enzyme active site by a double
amino acid substitution (37, 38).
Fig. 4. Drawing comparing the active site cavities of trifluoromethylphenol-
complexed D170SyT457E (black) and isoeugenol-complexed wild-type VAO
(gray). This figure was prepared with MOLSCRIPT (17).
Fig. 5. Schematic drawing of the hydration of the planar p-quinone methide intermediate of 4-ethylphenol in D170SyT457E. We propose that the
Glu-457-activated water attacks the quinone methide, yielding the (S)-enantiomer of the alcohol.








The results presented here underline the important role of
acidic residues for the function of VAO. In summary, Glu-457
can replace Asp-170 with respect to covalent flavin attachment,
but not with respect to efficient redox catalysis. The stereospec-
ificity of VAO depends on the position of the acidic residue in
the enzyme active site. With Asp-170 present, VAO is highly
stereospecific for the production of (R)-alcohols. However, the
enzyme becomes (S)-selective when the acidic residue is relo-
cated to the opposite face of the substrate-binding site.
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